Antidepressant effectiveness of deep Transcranial Magnetic Stimulation (dTMS) in patients with Major Depressive Disorder (MDD) with or without Alcohol Use Disorders (AUDs): A 6-month, open label, follow-up study

Journal of Affective Disorders

Volumn 174, Issue , 2015, Pages 57-63

  Rapinesi, Chiara ^a,b   Curto, Martina ^a,c,d   Kotzalidis, Georgios D ^a   Del Casale, Antonio ^a,e   Serata, Daniele ^a,b   Ferri, Vittoria Rachele ^a,b   Di Pietro, Simone ^a   Scatena, Paola ^a,b   Bersani, Francesco Saverio ^f   Raccah, Ruggero Nessim ^g   Digiacomantonio, Vittorio ^b   Ferracuti, Stefano ^a   Bersani, Giuseppe ^h   Zangen, Abraham ⁱ   Angeletti, Gloria ^a   Girardi, Paolo ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Suore Ospedaliere of the Sacred Heart of Jesus   (Italy)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MCLEAN HOSPITAL   (United States)

^e P Alberto Mileno Onlus Foundation   (Italy)

^f POLICLINICO UMBERTO I   (Italy)

^g ATID Ltd Advanced Technology   (Italy)

^h SAPIENZA UNIVERSITY OF ROME   (Italy)

ⁱ BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Alcohol; deep Transcranial Magnetic Stimulation (dTMS); Depression; Dorsolateral prefrontal cortex (DLPFC)

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; CLONAZEPAM; DIAZEPAM; DULOXETINE; LAMOTRIGINE; QUETIAPINE; SERTRALINE; TRAZODONE; VENLAFAXINE;

ADULT; ALCOHOL ABUSE; ALCOHOL USE DISORDER; ANTIDEPRESSANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL FEATURE; CLINICAL GLOBAL IMPRESSION SCALE; DEEP TRANSCRANIAL MAGNETIC STIMULATION; DEMOGRAPHY; DISEASE DURATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; FUNCTIONAL DISEASE; GLOBAL ASSESSMENT OF FUNCTIONING; HAMILTON SCALE; HUMAN; LEFT HEMISPHERE; MAJOR DEPRESSION; MALE; OBSESSIVE COMPULSIVE DRINKING SCALE; OPEN STUDY; PREFRONTAL CORTEX; PREVALENCE; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT RESISTANT DEPRESSION; WITHDRAWAL SYNDROME; AFFECT; ALCOHOLISM; CLINICAL TRIAL; COMPLICATION; DEPRESSIVE DISORDER, MAJOR; DRINKING BEHAVIOR; METHODOLOGY; MIDDLE AGED; OBSESSION; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ADULT; AFFECT; ALCOHOL DRINKING; ALCOHOLISM; DEPRESSIVE DISORDER, MAJOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OBSESSIVE BEHAVIOR; PREFRONTAL CORTEX; RESEARCH DESIGN; SEVERITY OF ILLNESS INDEX; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 84918779771     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2014.11.015     Document Type: Article

References (67)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition-Text Revision (DSM-IV-TR) 2000 American Psychiatric Association Washington, D.C
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) 2013 American Psychiatric Association Arlington, VA
3. R. Amiaz, D. Levy, D. Vainiger, L. Grunhaus, and A. Zangen Repeated high-frequency transcranial magnetic stimulation over the dorsolateral prefrontal cortex reduces cigarette craving and consumption Addiction 104 2009 653 660
4. R.F. Anton, D.H. Moak, and P. Latham The obsessive compulsive drinking scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior Alcohol. Clin. Exp. Res. 19 1995 92 99
5. S. Bajwa, F. Bermpohl, S.P. Rigonatti, A. Pascual-Leone, P.S. Boggio, and F. Fregni Impaired interhemispheric interactions in patients with major depression J. Nerv. Ment. Dis. 196 2008 671 677
6. R.C. Baldwin, and S. Simpson Treatment resistant depression in the elderly: a review of its conceptualisation, management and relationship to organic brain disease J. Affect. Disord. 46 1997 163 173
7. M.T. Berlim, F. Van den Eynde, S. Tovar-Perdomo, E. Chachamovich, A. Zangen, and G. Turecki Augmenting antidepressants with deep transcranial magnetic stimulation (DTMS) in treatment-resistant major depression World J. Biol. Psychiatry 15 2014 570 578 10.3109/15622975.2014.925141
8. F.S. Bersani, A. Minichino, P.G. Enticott, L. Mazzarini, N. Khan, G. Antonacci, R.N. Raccah, M. Salviati, R. Delle Chiaie, G. Bersani, P.B. Fitzgerald, and M. Biondi Deep transcranial magnetic stimulation as a treatment for psychiatric disorders: a comprehensive review Eur. Psychiatry 28 2013 30 39
9. M. Biondi, P. Parise, P. Venturi, L. Riccio, G. Brunetti, and P. Pancheri Frontal hemisphere lateralization and depressive personality traits Percept. Mot. Skills 77 1993 1035 1042
10. C. Blanco, A.A. Alegría, S.M. Liu, R. Secades-Villa, L. Sugaya, C. Davies, and E.V. Nunes Differences among major depressive disorder with and without co-occurring substance use disorders and substance-induced depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions J. Clin. Psychiatry 73 2012 865 873
11. P.S. Boggio, N. Sultani, S. Fecteau, L. Merabet, T. Mecca, A. Pascual-Leone, A. Basaglia, and F. Fregni Prefrontal cortex modulation using transcranial DC stimulation reduces alcohol craving: a double-blind, sham-controlled study Drug Alcohol Depend. 92 2008 55 60
12. P.S. Boggio, P. Liguori, N. Sultani, L. Rezende, S. Fecteau, and F. Fregni Cumulative priming effects of cortical stimulation on smoking cue-induced craving Neurosci. Lett. 463 2009 82 86
13. O.G. Bosch, M. Wagner, F. Jessen, K.U. Kühn, A. Joe, E. Seifritz, W. Maier, H.J. Biersack, and B.B. Quednow Verbal memory deficits are correlated with prefrontal hypometabolism in 18FDG PET of recreational MDMA users PLoS One 8 2013 e61234
14. L. Boschloo, N. Vogelzangs, J.H. Smit, W. van den Brink, D.J. Veltman, A.T. Beekman, and B.W. Penninx Comorbidity and risk indicators for alcohol use disorders among persons with anxiety and/or depressive disorders: findings from the Netherlands Study of Depression and Anxiety (NESDA) J. Affect. Disord. 131 2011 233 242
15. J.A. Camprodon, J. Martínez-Raga, M. Alonso-Alonso, M.C. Shih, and A. Pascual-Leone One session of high frequency repetitive transcranial magnetic stimulation (rTMS) to the right prefrontal cortex transiently reduces cocaine craving Drug Alcohol Depend. 86 2007 91 94
16. C.C. Chang, S.C. Yu, D.R. McQuoid, D.F. Messer, W.D. Taylor, K. Singh, B.D. Boyd, K.R. Krishnan, J.R. MacFall, D.C. Steffens, and M.E. Payne Reduction of dorsolateral prefrontal cortex gray matter in late-life depression Psychiatry Res. 193 2011 1 6
17. D. Chisholm, P. Diehr, M. Knapp, D. Patrick, M. Treglia, and G. Simon Depression status, medical comorbidity and resource costs. Evidence from an international study of major depression in primary care (LIDO) Br. J. Psychiatry 183 2003 121 131
18. J. Endicott, R.L. Spitzer, and J.L. Fleiss The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance Arch. Gen. Psychiatry 33 1976 766 771
19. M. Feeser, K. Prehn, P. Kazzer, A. Mungee, and M. Bajbouj Transcranial direct current stimulation enhances cognitive control during emotion regulation Brain Stimul. 7 2014 105 112
20. J. Feil, and A. Zangen Brain stimulation in the study and treatment of addiction Neurosci. Biobehav. Rev. 34 2010 559 574
21. M.B. First, M. Gibbon, R.L. Spitzer, J.B.W. Williams, and L.S. Benjamin Structured Clinical Interview for DSM-IV Axis II Personality Disorders, (SCID-II) 1997 American Psychiatric Press, Inc. Washington, D.C.
22. M.B. First, R.L. Spitzer, M. Gibbon, and J.B.W. Williams Structured Clinical Interview for DSM-IV Axis I Disorders, Research Version, Patient Edition 2002 Biometric Research, New York State Psychiatric Institute New York A1 A46
23. Food and Drug Administration, 2013. Brainsway deep TMS system, 510(k) Number K122288. 〈http://www.accessdata.fda.gov/cdrh-docs/pdf12/k122288.pdf〉 (accessed 31.07.14.).
24. A.M. Gadermann, J. Alonso, G. Vilagut, A.M. Zaslavsky, and R.C. Kessler Comorbidity and disease burden in the National Comorbidity Survey Replication (NCS-R) Depress. Anxiety 29 2012 797 806
25. P. Girardi, C. Rapinesi, F. Chiarotti, G.D. Kotzalidis, D. Piacentino, D. Serata, A. Del Casale, P. Scatena, F. Mascioli, R.N. Raccah, R. Brugnoli, V. Digiacomantonio, V.R. Ferri, S. Ferracuti, A. Zangen, and G. Angeletti Add-on deep transcranial magnetic stimulation (dTMS) in patients with dysthymic disorder comorbid with alcohol use disorder: a comparison with standard treatment World J. Biol. Psychiatry 2014 10.3109/15622975.2014.925583
26. B.F. Grant, F.S. Stinson, D.A. Dawson, S.P. Chou, M.C. Dufour, W. Compton, R.P. Pickering, and K. Kaplan Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions Arch. Gen. Psychiatry 61 2004 807 816
27. B.L. Greenfield, K.L. Venner, J.F. Kelly, V. Slaymaker, and A.D. Bryan The impact of depression on abstinence self-efficacy and substance use outcomes among emerging adults in residential treatment Psychol. Addict. Behav. 26 2012 246 254
28. S. Grimm, J. Beck, D. Schuepbach, D. Hell, P. Boesiger, F. Bermpohl, L. Niehaus, H. Boeker, and G. Northoff Imbalance between left and right dorsolateral prefrontal cortex in major depression is linked to negative emotional judgment: an fMRI study in severe major depressive disorder Biol. Psychiatry 63 2008 369 376
29. W. Guy ECDEU Assessment Manual of Psychopharmacology - Revised (DHEW Publ No. ADM 76-338) 1976 Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs Rockville, MD, USA 218 222
30. M. Hamilton A rating scale for depression J. Neurol. Neurosurg. Psychiatry 23 1960 56 62
31. E.V. Harel, L. Rabany, L. Deutsch, Y. Bloch, A. Zangen, and Y. Levkovitz H-coil repetitive transcranial magnetic stimulation for treatment resistant major depressive disorder: an 18-week continuation safety and feasibility study World J. Biol. Psychiatry 15 2014 298 306
32. E. Jane-Llopis, and I. Matytsina Mental health and alcohol, drugs and tobacco: a review of the comorbidity between mental disorders and the use of alcohol, tobacco and illicit drugs Drug Alcohol Rev. 25 2006 515 536
33. T.J. Kaptchuk, P. Goldman, D.A. Stone, and W.B. Stason Do medical devices have enhanced placebo effects? J. Clin. Epidemiol. 53 2000 786 792
34. R.C. Kessler, P. Berglund, O. Demler, R. Jin, D. Koretz, K.R. Merikangas, A.J. Rush, E.E. Walters, P.S. Wang National Comorbidity Survey Replication The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) J. Am. Med. Assoc. 289 2003 3095 3105
35. M. Koenigs, and J. Grafman The functional neuroanatomy of depression: distinct roles for ventromedial and dorsolateral prefrontal cortex Behav. Brain Res. 201 2009 239 243
36. N. Lang, A. Hasan, E. Sueske, W. Paulus, and M.A. Nitsche Cortical hypoexcitability in chronic smokers? A transcranial magnetic stimulation study Neuropsychopharmacology 33 2008 2517 2523
37. Y. Lecrubier How do you define remission? Acta Psychiatr. Scand. 106 415 2002 7 11
38. Y. Levkovitz, E.V. Harel, Y. Roth, Y. Braw, D. Most, L.N. Katz, A. Sheer, R. Gersner, and A. Zangen Deep transcranial magnetic stimulation over the prefrontal cortex: evaluation of antidepressant and cognitive effects in depressive patients Brain Stimul. 2 2009 188 200
39. X. Li, K.J. Hartwell, M. Owens, T. Lematty, J.J. Borckardt, C.A. Hanlon, K.T. Brady, and M.S. George Repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex reduces nicotine cue craving Biol. Psychiatry 73 2013 714 720
40. Y. Ma Neuropsychological mechanism underlying antidepressant effect: a systematic meta-analysis (Epub ahead of print) Mol. Psychiatry 2014 10.1038/mp.2014.24
41. F. Maeda, J.P. Keenan, and A. Pascual-Leone Interhemispheric asymmetry of motor cortical excitability in major depression as measured by transcranial magnetic stimulation Br. J. Psychiatry 177 2000 169 173
42. V. Maletic, M. Robinson, T. Oakes, S. Iyengar, S.G. Ball, and J. Russell Neurobiology of depression: an integrated view of key findings Int. J. Clin. Pract. 61 12 2007 2030 2040
43. D.M. McLoughlin, A. Mogg, S. Eranti, G. Pluck, R. Purvis, D. Edwards, S. Landau, R. Brown, S. Rabe-Heskith, R. Howard, M. Philpot, J. Rothwell, R. Romeo, and M. Knapp The clinical effectiveness and cost of repetitive transcranial magnetic stimulation versus electroconvulsive therapy in severe depression: a multicentre pragmatic randomised controlled trial and economic analysis Health Technol. Assess. 11 24 2007 1 54
44. A. Minichino, F.S. Bersani, E. Capra, R. Pannese, C. Bonanno, M. Salviati, R. Delle Chiaie, and M. Biondi ECT, rTMS, and deepTMS in pharmacoresistant drug-free patients with unipolar depression: a comparative review Neuropsychiatr. Dis. Treat. 8 2012 55 64
45. B.R. Mishra, S.H. Nizamie, B. Das, and S.K. Praharaj Efficacy of repetitive transcranial magnetic stimulation in alcohol dependence: a sham-controlled study Addiction 105 2010 49 55
46. L. Moreno-López, E.A. Stamatakis, M.J. Fernández-Serrano, M. Gómez-Río, A. Rodríguez-Fernández, M. Pérez-García, and A. Verdejo-García Neural correlates of the severity of cocaine, heroin, alcohol, MDMA and cannabis use in polysubstance abusers: a resting-PET brain metabolism study PLoS One 7 2012 e39830
47. R. Nardone, J. Bergmann, M. Christova, P. Lochner, F. Tezzon, S. Golaszewski, E. Trinka, and F. Brigo Non-invasive brain stimulation in the functional evaluation of alcohol effects and in the treatment of alcohol craving: a review Neurosci. Res. 74 2012 169 176
48. C.B. Nemeroff Prevalence and management of treatment-resistant depression J. Clin. Psychiatry 68 8 2007 17 25
49. E.V. Nunes, D. Deliyannides, S. Donovan, and P.J. McGrath The management of treatment resistance in depressed patients with substance use disorders Psychiatr. Clin. North Am. 19 1996 311 327
50. D.H. Oh, H. Son, S. Hwang, and S.H. Kim Neuropathological abnormalities of astrocytes, GABAergic neurons, and pyramidal neurons in the dorsolateral prefrontal cortices of patients with major depressive disorder Eur. Neuropsychopharmacol. 22 2012 330 338
51. H.M. Olbrich, G. Valerius, C. Paris, F. Hagenbuch, D. Ebert, and F.D. Juengling Brain activation during craving for alcohol measured by positron emission tomography Aust. N.Z. J. Psychiatry 40 2006 171 178
52. E. Politi, E. Fauci, A. Santoro, and E. Smeraldi Daily sessions of transcranial magnetic stimulation to the left prefrontal cortex gradually reduce cocaine craving Am. J. Addict. 17 2008 345 346
53. J. Pripfl, L. Tomova, I. Riecansky, and C. Lamm Transcranial magnetic stimulation of the left dorsolateral prefrontal cortex decreases cue-induced nicotine craving and EEG delta power Brain Stimul. 7 2014 226 233
54. C. Rapinesi, G.D. Kotzalidis, D. Serata, A. del Casale, F.S. Bersani, A. Solfanelli, P. Scatena, R.N. Raccah, R. Brugnoli, V. Digiacomantonio, P. Carbonetti, C. Fensore, R. Tatarelli, G. Angeletti, S. Ferracuti, and P. Girardi Efficacy of add-on deep transcranial magnetic stimulation in comorbid alcohol dependence and dysthymic disorder: three case reports Prim. Care Companion CNS Disord. 15 1 2013 10.4088/PCC.12m01438 (pii:PCC.12m01438)
55. J. Rehm, C. Mathers, S. Popova, M. Thavorncharoensap, Y. Teerawattananon, and J. Patra Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders Lancet 373 2009 2223 2233
56. R. Richieri, E. Guedj, P. Michel, A. Loundou, P. Auquier, C. Lançon, and L. Boyer Maintenance transcranial magnetic stimulation reduces depression relapse: a propensity-adjusted analysis J. Affect. Disord. 151 2013 129 135
57. O. Rosenberg, N. Shoenfeld, A. Zangen, M. Kotler, and P.N. Dannon Deep TMS in a resistant major depressive disorder: a brief report Depress. Anxiety 27 2010 465 469
58. O. Rosenberg, A. Zangen, R. Stryjer, M. Kotler, and P.N. Dannon Response to deep TMS in depressive patients with previous electroconvulsive treatment Brain Stimul. 3 2010 211 217
59. Y. Roth, A. Amir, Y. Levkovitz, and A. Zangen Three-dimensional distribution of the electric field induced in the brain by transcranial magnetic stimulation using figure-8 and deep H-coils J. Clin. Neurophysiol. 24 2007 31 38
60. M.A. Schuckit Comorbidity between substance use disorders and psychiatric conditions Addiction 101 2006 76 88
61. J.A. Silvers, J. Weber, T.D. Wager, and K.N. Ochsner Bad and worse: neural systems underlying reappraisal of high- and low-intensity negative emotions (Epub ahead of print) Soc. Cogn. Affect. Neurosci. 2014 10.1093/scan/nsu043
62. Z. Sjoerds, W. van den Brink, A.T. Beekman, B.W. Penninx, and D.J. Veltman Response inhibition in alcohol-dependent patients and patients with depression/anxiety: a functional magnetic resonance imaging study Psychol. Med. 44 2014 1713 1725
63. F. Spagnolo, M.A. Volonté, M. Fichera, R. Chieffo, E. Houdayer, M. Bianco, E. Coppi, A. Nuara, L. Straffi, G. Di Maggio, L. Ferrari, D. Dalla Libera, S. Velikova, G. Comi, A. Zangen, and L. Leocani Excitatory deep repetitive transcranial magnetic stimulation with H-coil as add-on treatment of motor symptoms in Parkinson's disease: an open label, pilot study Brain Stimul. 7 2014 297 300
64. J.D. Swendsen, and K.R. Merikangas The comorbidity of depression and substance use disorders Clin. Psychol. Rev. 20 2000 173 189
65. M.E. Thase, and A.J. Rush When at first you don't succeed: sequential strategies for antidepressant nonresponders J. Clin. Psychiatry 58 13 1997 23 29
66. World Health Organization The World Health Report, 2000. Health Systems: Improving Performance 2000 World Health Organization Genève (CH)
67. T. Ye, J. Peng, B. Nie, J. Gao, J. Liu, Y. Li, G. Wang, X. Ma, K. Li, and B. Shan Altered functional connectivity of the dorsolateral prefrontal cortex in first-episode patients with major depressive disorder Eur. J. Radiol. 81 2012 4035 4040